SynthesisBMC gastroenterology2024

Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.

Xinming Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.